Evidence map›Paper›PMID 39416531›Full record

ArticleCureus2024

Fatal Mucormycosis in a Diabetic Patient: A Case Report and Review of Diagnostic Challenges.

John Overton, Ariel Velasquez, Allison Cruse, Caitlin Noble, Robert Burrow, Poonam C Sharma, William P Berlin, Robert T Brodell, Sumit P Sontakke

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

John OvertonMedicine, University of Mississippi Medical Center, Jackson, USA.
Ariel VelasquezPathology, University of Mississippi Medical Center, Jackson, USA.
Allison CruseDermatology and Pathology, University of Mississippi Medical Center, Jackson, USA.
Caitlin NobleDermatology and Pathology, University of Mississippi Medical Center, Jackson, USA.
Robert BurrowDermatology, University of Mississippi Medical Center, Jackson, USA.
Poonam C SharmaPathology, University of Mississippi Medical Center, Jackson, USA.
William P BerlinRadiology, University of Mississippi Medical Center, Jackson, USA.
Robert T BrodellDermatology, University of Mississippi Medical Center, Jackson, USA.
Sumit P SontakkeMedical Foundations, Ross University School of Medicine, St. Michael, BRB.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mucormycosis (zygomycosis) is a severe and often fatal mycotic infection affecting primarily immunocompromised individuals. A 61-year-old female with type 2 diabetes mellitus and end-stage renal disease developed septic shock in association with mucormycosis. Despite antifungal treatment with liposomal amphotericin B, the patient's condition rapidly deteriorated, leading to death within 48 hours. This case underscores the aggressive nature of mucormycosis, highlighting the necessity for early diagnosis using advanced diagnostic tools and prompt treatment to improve patient outcomes.

Indexed as

immunocompromisedmucormycosisrhizopusseptic shockzygomycosis

Identifiers

PMID39416531
PMCPMC11483154

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.